Dr. Cesar Delaguila, MD

Dr. Delaguila practices at Powell Valley Clinic in Powell, Wyoming.

Dr. Delaguila's NPI, 1225019136, was assigned on November 8, 2005. Dr. Delaguila graduated from Cayetano Heredia University in 1985. Dr. Delaguila holds Texas license M5124.

Dr. Delaguila's primary practice is Powell Valley Clinic, at 777 Ave H, Powell, WY 82435. The practice phone is (307) 754-7257.

Dr. Delaguila's primary practice is Powell Valley Clinic in Powell, Wyoming. Dr. Delaguila is also affiliated with Albany Medical Center. The medical group on file is Powell Valley Clinic. Dmand AI also links Dr. Delaguila to 4 more hospitals, 3 medical groups and 1 physician office, each named with a free account. Dr. Delaguila's employer is on file too: an urgent care center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Delaguila practices, 7 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Delaguila's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Delaguila is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Delaguila's licenses on file in 6 states: Texas, Montana, Maine, Wyoming, Louisiana and Michigan.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic hypertension and chronic skin ulcer among the conditions Dr. Delaguila treats.

CMS data shows 697 Medicare services from Dr. Delaguila across 7 procedure codes in 2024, for 299 Medicare patients. Medicare paid $31,592 for them.

CMS counts 299 Medicare patients who saw Dr. Delaguila in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Delaguila's median patient age at 76, with 43% women.

In 2024, Dr. Delaguila wrote 2,785 Medicare Part D claims for 390 patients. 76% of them were for generic drugs. CMS names the drug for 2,559 of them, across 36 drugs with 11 or more claims each, at $626,941 in total drug cost. In 2023, CMS named 3,199 claims across 40 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for Dr. Delaguila for performance year 2024, reported through an alternative payment model (APM). Dr. Delaguila accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 348 general payments to Dr. Delaguila from 26 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Biotronik Inc. paid the most, $6,166.

Dr. Delaguila graduated from Cayetano Heredia University in 1985.

Dr. Delaguila is in network with 8 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.